Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia

Journal of Cachexia, Sarcopenia and Muscle

Volumn 8, Issue 4, 2017, Pages 523-526

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Anorexia; Cachexia; Sarcopenia

Indexed keywords

AMYLIN; ANAMORELIN; BOMBESIN; CORTICOTROPIN RELEASING FACTOR; DRONABINOL; GASTRIN RELEASING PEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LACTIC ACID; MEGESTROL ACETATE; MELANOCORTIN; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; PRALMORELIN;

AGING; ANOREXIA; CACHEXIA; CYTOKINE PRODUCTION; EDITORIAL; FAT MASS; FOOD INTAKE; HUMAN; HYPERTRIGLYCERIDEMIA; MUSCLE MASS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SARCOPENIA; SATIETY; STOMACH PARESIS; WEIGHT REDUCTION; AGED; BODY WEIGHT LOSS; METABOLISM; PHYSIOLOGY;

AGED; AGING; ANOREXIA; CACHEXIA; HUMANS; SARCOPENIA; SATIATION; WEIGHT LOSS;

EID: 85018293482     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12192     Document Type: Editorial

References (64)

1. von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc 2014;15:866–872.
2. Ezeoke CC, Morley JE. Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 2015;6:287–302.
3. von Haehling S, Morley JE, Ankder SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia and Muscle 2010;1:129–133.
4. Morley JE. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci 2003;58:131–137.
5. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging 2008;12:452–456.
6. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Barillaro C, et al. Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study. Eur J Nutr 2013;52:1261–1268.
7. Soenen S, Chapman IM. Body weight, anorexia, and undernutrition in older people. J Am Med Dir Assoc 2013;14:642–648.
8. Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, et al. Anorexia of aging: risk factors, consequences and potential treatments. Nutrients 2016;8:69.
9. Morley JE. Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 2013;16:27–32.
10. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012;3:1–4.
11. Lee JS, Auyeung TW, Chau PP, Hui E, Chan F, Chi I, et al. Obesity can benefit survival- a 9-year prospective study in 1614 Chinese nursing home residents. J Am Med Dir Assoc 2014;15:342–348.
12. Porter Starr KN, McDonald SR, Bales CW. Obestiy and physical frailty in older adults: a scoping review of lifestyle intervention trials. J Am Med Dir Assoc 2014;15:240–250.
13. Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, et al. Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J Am Med Dir Assoc 2015;16:933–939.
14. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013;14:877–882.
15. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793–799.
16. Devic S. Warburg effect—a consequence or the cause of carcinogenesis? J Cancer 2016;7:817–822.
17. Morley JE, Thomas DR. Cachexia: new advances in the management of wasting diseases. J Am Med Dir Assoc 2008;9:205–210.
18. Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, et al. Anorexia of Aging: risk factors, consequences, and potential treatments. Nutrients 2016;8:69.
19. Morley JE. Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 2013;16:27–32.
20. Morley JE. Anorexia of aging: a true geriatric syndrome. J Nutr Health Aging 2012;16:422–425.
21. Jones KL, Sm D, Hveem K, Bartholomeusz FD, Morley JE, Sun WM, et al. Relation between postprandial satiation and antral area in normal subjects. Am J Clin Pract 1997;66:127–132.
22. Sturm K, Parker B, Wishart J, Feinle-Bisset C, Jones KL, Chapman I, et al. Energy intake and appetite are related to antral area in healthy young and older subjects. Am J Clin Nutr 2004;80:656–667.
23. Clarkston WK, Pantano MM, Morley JE, Horowitz M, Littlefiend JM, Burton FR. Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs. young adults. Am J Physiol 1997;272:R243–R248.
24. Wilson MMG, Purushothaman R, Morley JE. Effect of liquid dietary supplements on energy intake in the elderly. Am J Clin Nutr 2002;75:944–947.
25. Silver AJ, Flood JF, Song AM, Morley JE. Evidence for a physiological role for CCK in the regulation of food intake in mice. Am J Physiology 1989;256:R646–R652.
26. MacIntosh CG, Morley JE, Wishart J, Morris H, Jansen JB, Horowitz M, et al. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCD, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 2001;86:5830–5837.
27. MacIntosh CG, Morley JE, Wishart J, Morris H, Jansen JB, Horowitz M, et al. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 2001;86:5830–5837.
28. Morley JE, Levine AS. Bomesin inhibits stress induced eating. Pharmacology Biochemistry and Behavior 1981;14:149–152.
29. Lee A, Patrick P, Wishart J, Horowitz M, Morley JE. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab 2002;4:329–335.
30. Morley JE, Dk M, Perry HM 3rd, Patrick P, Guigoz Y, Vellas B. Anorexia of aging, leptin, and the mini nutritional assessment. Nestle Nutr Workshop Ser Clin Perform Programme 1999;1:67–76.
31. Morley JE, Alshaher MM, Farr SA, Flood JF, Kumar VB. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding. Paptides 1999;20:595–600.
32. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, et al. Triglycerides induce leptin resistance at the blood–brain barrier. Diabetes 2004;53:1253–1260.
33. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661–1667.
34. Morley JE, Farr SA. Cachexia and neuropeptide Y. Nutrition 2008;24:815–819.
35. Anker SD, Coats AJ, Morley JE. Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin. J Cachexia Sarcopenia Muscle 2015;6:275–277.
36. Pietra C, Takeda Y, Tazawa-Ogata N, Minami M, Yuanfeng X, Duus EM, et al. Anamorelin HCI (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle 2014;5:329–337.
37. Dwarkasing JT, van Dijk M, Dijk FJ, Boekschoten MV, Faber J, Argiles JM, et al. Hypothalamic food intake regulation in a cancer-cachectic mouse model. J Cachexia Sarcopenia Muscle 2014;5:159–169.
38. Morley JE. Peptides and aging: their role in anorexia and memory. Peptides 2015;72:112–118.
39. Morley JE, Farr SA. Cachexia and neuropeptide Y. Nutrition 2008;24:815–819.
40. Seeliger S, Janssen PH, Schink B. Energetics and kinetics of lactate fermentation to acetate and proprionate via methylmalonyl-CoA or acrylyl-CoA. FEMS Microbiol Lett 2002;211:65–70.
41. Dwarkasing JT, Boekschoten MV, Argiles JM, van Dijk M, Busquets S, Penna F, et al. Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signaling. J Cachexia Sarcopenia Muscle 2015;6:84–94.
42. Gaskin FS, Farr SA, Banks WA, Kumar VB, Morley JE. Ghrelin-induced feeding is dependent on nitric oxide. Peptides 2003;24:913–918.
43. Haruta I, Fuku Y, Kinoshita K, Yoneda K, Morinaga A, Amitani M, et al. One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient. J Cachexia Sarcopenia Muscle 2015;6:237–241.
44. Argiles JM, Muscaritoli M. The three faces of sarcopenia. J Am Med Dir Assoc 2016;17:471–472.
45. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.
46. Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 2016;98:319–333.
47. Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc 2013;14:10–17.
48. Tsai VW, Husaini Y, Manandhar R, Lee-Ng KK, Zhang HP, Harriott K, et al. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. J Cachexia Sarcopenia Muscle 2012;3:239–243.
49. Argiles JM, Muscaritoli M. The three faces of sarcopenia. J Am Med Dir Assoc 2016;17:471–472.
50. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013;14:877–882.
51. Morley JE, von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle 2014;5:5–8.
52. Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478–1486.
53. Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Design 2009;15:3384–3395.
54. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Agign 2012;16:601–608.
55. Anker SD, Morley JE. Cachexia: a nutritional syndrome? J Cachexia Sarcopenia Muscle 2015;6:269–271.
56. Cooper C, Burden ST, Cheng H, Molassiotis A. Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle 2015;6:99–111.
57. Poisson P, Barberger-Gateau P, Tulon A, Campos S, Dupuis V, Bourdel-marchasson I. Efficiency at the resdient's level of the NABUCCOD nutrition and oral health care training program in nursing homes. J Am Med Dir Assoc 2014;15:290–295.
58. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:391–396.
59. Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2015;16:740–747.
60. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group. J Am Med Dir Assoc 2013;14:542–559.
61. Wilson MM, Philpot C, Morley JE. Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?—a pilot study. J Nutr Health Aging 2007;11:195–198.
62. Karcic E, Philpot C, Morley JE. Treating malnutrition with megestrol acetate: literature review and review of our experience. J Nutr Health Aging 2002;6:191–200.
63. Morley JE, von Haehling S, Anker SD. Are we closer to having drugs to treat muscle wasting disease? J Cachexia Sarcopenia Muscle 2014;5:83–87.
64. vonHaehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. J Cachexia Sarcopenia Muscle 2015;6:315–316.